Analysts See $-0.19 EPS for Mesoblast Limited (MESO); Profile of 9 Analysts Covering Cabot (CBT)

February 19, 2018 - By Richard Conner

Analysts expect Mesoblast Limited (NASDAQ:MESO) to report $-0.19 EPS on February, 26.They anticipate $0.07 EPS change or 26.92% from last quarter’s $-0.26 EPS. After having $-0.08 EPS previously, Mesoblast Limited’s analysts see 137.50% EPS growth. The stock decreased 2.19% or $0.1142 during the last trading session, reaching $5.0958. About 33,745 shares traded. Mesoblast Limited (NASDAQ:MESO) has risen 19.87% since February 19, 2017 and is uptrending. It has outperformed by 3.17% the S&P500.

Among 11 analysts covering Cabot (NYSE:CBT), 9 have Buy rating, 0 Sell and 2 Hold. Therefore 82% are positive. Cabot had 25 analyst reports since August 13, 2015 according to SRatingsIntel. The stock has “Buy” rating by SunTrust on Tuesday, December 19. The stock of Cabot Corporation (NYSE:CBT) has “Buy” rating given on Thursday, February 8 by Jefferies. The firm has “Hold” rating given on Wednesday, September 6 by KeyBanc Capital Markets. Northcoast maintained Cabot Corporation (NYSE:CBT) on Monday, February 12 with “Buy” rating. The rating was maintained by Deutsche Bank on Friday, August 12 with “Hold”. The stock has “Buy” rating by Jefferies on Tuesday, October 10. Jefferies maintained the shares of CBT in report on Thursday, July 13 with “Buy” rating. The firm has “Sell” rating given on Tuesday, September 1 by Zacks. Jefferies maintained the shares of CBT in report on Thursday, June 8 with “Buy” rating. The stock of Cabot Corporation (NYSE:CBT) earned “Neutral” rating by SunTrust on Tuesday, August 2. See Cabot Corporation (NYSE:CBT) latest ratings:




12/02/2018 Broker: Northcoast Rating: Buy New Target: $75.0 Maintain
08/02/2018 Broker: Jefferies Rating: Buy New Target: $78.0 Maintain
26/01/2018 Broker: Needham Rating: Buy New Target: $120.0
05/01/2018 Broker: Loop Capital Old Rating: Hold New Rating: Buy Old Target: $59 New Target: $82 Upgrade
19/12/2017 Broker: Suntrust Robinson Old Rating: Hold New Rating: Buy Upgrade
19/12/2017 Broker: SunTrust Old Rating: Hold New Rating: Buy Upgrade
02/11/2017 Broker: Jefferies Rating: Buy New Target: $74.0 Maintain
31/10/2017 Broker: KeyBanc Capital Markets Rating: Hold Maintain
10/10/2017 Broker: Jefferies Rating: Buy New Target: $68.0 Maintain
29/09/2017 Broker: Loop Capital Rating: Hold New Target: $59 Initiates Coverage On

The stock decreased 0.85% or $0.55 during the last trading session, reaching $63.9. About 397,924 shares traded. Cabot Corporation (NYSE:CBT) has risen 15.44% since February 19, 2017 and is uptrending. It has underperformed by 1.26% the S&P500.

Investors sentiment decreased to 0.99 in 2017 Q3. Its down 0.26, from 1.25 in 2017Q2. It fall, as 24 investors sold Cabot Corporation shares while 89 reduced holdings. 32 funds opened positions while 80 raised stakes. 51.85 million shares or 0.30% more from 51.70 million shares in 2017Q2 were reported. Her Majesty The Queen In Right Of The Province Of Alberta As Represented By Alberta Mgmt stated it has 112,461 shares or 0.06% of all its holdings. Bbva Compass Retail Bank Incorporated holds 0.04% or 10,156 shares in its portfolio. Alliancebernstein Lp reported 42,866 shares. Commonwealth Of Pennsylvania Pub School Empls Retrmt accumulated 9,078 shares. Icon Advisers Inc Co, a Colorado-based fund reported 7,000 shares. California State Teachers Retirement System, a California-based fund reported 102,218 shares. Utah Retirement System accumulated 11,127 shares. Us Financial Bank De stated it has 21,671 shares. Fny Managed Accounts Lc stated it has 684 shares or 0.05% of all its holdings. Mason Street Advisors Lc has invested 0.04% in Cabot Corporation (NYSE:CBT). 1.74M are owned by State Street. New York State Teachers Retirement System owns 113,782 shares for 0.02% of their portfolio. Smith Asset Mgmt Grp Limited Partnership holds 730 shares. Sei has invested 0.01% of its portfolio in Cabot Corporation (NYSE:CBT). Brandywine Glob Investment Ltd Liability Corporation has 218,961 shares.

Since September 14, 2017, it had 0 insider buys, and 1 insider sale for $207,207 activity. The insider Kalkstein Hobart sold 3,881 shares worth $207,207.

Cabot Corporation operates as a specialty chemicals and performance materials company. The company has market cap of $3.95 billion. The firm offers carbon black, a form of elemental carbon used to enhance the physical properties of the systems and applications in which it is incorporated; and rubber blacks for use as a rubber reinforcing agent and performance additive in tires, hoses, belts, extruded profiles, and molded goods. It has a 64.74 P/E ratio. It also provides compounds of carbon black and rubber primarily for tire applications; and cesium formate, a drilling and completion fluid for use in high pressure and high temperature gas and oil well construction.

Mesoblast Limited develops cell-based medicines. The company has market cap of $465.68 million. The firm has leveraged its proprietary technology platform based on mesenchymal lineage adult stem cells to establish a portfolio of late-stage product candidates. It currently has negative earnings. The Company’s allogeneic cell product candidates target advanced stages of diseases with high and unmet medical needs, including cardiovascular conditions, immunologic and inflammatory conditions, orthopedic disorders, and oncology and hematology conditions.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.